Mark Gilbert

The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients.

Clinical trial end points for high-grade glioma: the evolving landscape.

A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.

Portraits of care: medical research through portraiture.

Central nervous system cancers.

Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes Project.

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.

Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.

Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

It is time to include patients with brain tumors in phase I trials in oncology.

Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Towards targeted screening for acute HIV infections in British Columbia.

Feasibility of incorporating self-collected rectal swabs into a community venue-based survey to measure the prevalence of HPV infection in men who have sex with men.

Alveolar ridge mucosa protection during suspension laryngoscopy in the edentulous patient.

Predictors of survival among older adults with ependymoma.

Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor.

Improving patient outcomes in glioblastoma through integration of recent data: introduction.

Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.

Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.

Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.

Glioblastoma.

Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.

A prognostic gene expression signature in infratentorial ependymoma.

Online sexual health services: examining youth's perspectives.

Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer.

Internet-based HIV and sexually transmitted infection testing in British Columbia, Canada: opinions and expectations of prospective clients.

Congruence of primary brain tumor patient and caregiver symptom report.

Masculinities, 'guy talk' and 'manning up': a discourse analysis of how young men talk about sexual health.

Evaluation of online partner notification services like inSPOT requires starting with the client, not the clinic.

Personal health records as portal to the electronic medical record.

Implications for HIV prevention programs from a serobehavioural survey of men who have sex with men in Vancouver, British Columbia: the ManCount study.

Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.

Incidental thyroid cancer found during surgery for head and neck squamous cell carcinoma.

Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs.

Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.

Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

Young people's perspectives on the use of reverse discourse in web-based sexual-health interventions.

Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT).

Minding the Ps and Qs: perseverance and quality studies lead to major advances in patients with anaplastic oligodendroglioma.

Practical strategies for management of fatigue and sleep disorders in people with brain tumors.

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy.

Heteronormativity hurts everyone: experiences of young men and clinicians with sexually transmitted infection/HIV testing in British Columbia, Canada.

On the pathway to success: defining subtypes of gliomas for better treatment selection and refining the meaning of success.

Textiloma resembling anaplastic progression of an isocitrate dehydrogenase 1 (IDH1) mutant, low grade glioma.

Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.

Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept.

Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada.

Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.

Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide.

Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.

Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.

Impact of statistical adjustment for frequency of venue attendance in a venue-based survey of men who have sex with men.

Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.

Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling.

Treatment recommendations for anaplastic oligodendrogliomas that are codeleted.

Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia.

Risks for HIV and other sexually transmitted infections among Asian men who have sex with men in Vancouver, British Columbia: a cross-sectional survey.

Central nervous system cancers.

The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.

MicroRNAs as novel immunotherapeutics.

Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis.

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial.

Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma.

Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol.

Clinical significance of intraparotid lymph node metastasis in primary parotid cancer.

Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein.

Factors associated with intention to use internet-based testing for sexually transmitted infections among men who have sex with men.

Risk prediction in sexual health contexts: protocol.

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

Short message service (SMS) interventions for the prevention and treatment of sexually transmitted infections: a systematic review protocol.

Establishing the standard of care for patients with newly diagnosed and recurrent glioblastoma.

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.

Spreading speeds for stage structured plant populations in fragmented landscapes.

Targeted therapy in gliomas.

Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

HIV-negative gay men's accounts of using context-dependent sero-adaptive strategies.

Examining the scope of public health nursing practice in sexually transmitted infection prevention and management: what do nurses do?

Pregnancy and glial brain tumors.

Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC).

Alternative strategies for partner notification: a missing piece of the puzzle.

A critical appraisal of risk models for predicting sexually transmitted infections.

Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006-2011.

Reply to M.C. Chamberlain.

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes.

Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted).

Bevacizumab for newly diagnosed glioblastoma.

Test uptake and case detection of syphilis, HIV, and hepatitis C among women undergoing prenatal screening in British Columbia, 2007 to 2011.

Is level V neck dissection necessary in primary parotid cancer?

Advances in treating glioblastoma.

Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling.

Renewing interest in targeting angiogenesis in glioblastoma.

Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays.

Process monitoring of an HIV treatment as prevention program in British Columbia, Canada.

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Pectoralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy.

Spreading speeds for plant populations in landscapes with low environmental variation.

Relationship between disclosure of same-sex sexual activity to providers, HIV diagnosis and sexual health services for men who have sex with men in Vancouver, Canada.

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.

Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients.

Diagnostic technologies in practice: gay men's narratives of acute or recent HIV infection diagnosis.

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines.

Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2.

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.

Misclassification and Undersampling of Sexual Minorities in Population Surveys.

Facing the future of brain tumor clinical research.

Sinking skin flap syndrome in glioblastoma.

A cross-sectional survey exploring attitudes towards provincial electronic health record implementation among clients attending the Provincial Sexually Transmitted Infections Clinic in British Columbia.

Current challenges in designing GBM trials for immunotherapy.

Deriving and validating a risk estimation tool for screening asymptomatic chlamydia and gonorrhea.

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.

Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.

Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

HIV testing behaviour and use of risk reduction strategies by HIV risk category among MSM in Vancouver.

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Treating recurrent glioblastoma: an update.

Significant predictors of patients' uncertainty in primary brain tumors.

An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).

The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic.

Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.

Genetic Modulation of Neurocognitive Function in Glioma Patients.

A validation study of a clinical prediction rule for screening asymptomatic chlamydia and gonorrhoea infections among heterosexuals in British Columbia.

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy.

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

Venous thromboembolism (VTE) and glioblastoma.

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.

Impact of recall period on primary brain tumor patient's self-report of symptoms.

Personal health records, symptoms, uncertainty, and mood in brain tumor patients.

Primary brain tumors and posterior reversible encephalopathy syndrome.

Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011.

Hope and mood changes throughout the primary brain tumor illness trajectory.

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis.

Becoming "Undetectable": Longitudinal Narratives of Gay Men's Sex Lives After a Recent HIV Diagnosis.

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.

Wound healing complications in brain tumor patients on Bevacizumab.

Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Central Nervous System Cancers, Version 1.2015.

A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.

Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.

Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

Advances in the treatment of newly diagnosed glioblastoma.

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

Diagnosis of a growing radiation-induced skull lesion in a patient: an unusual scar.

PHOTO QUIZ. An Unusual Cause of Abdominal Pain and Fever in a Diabetic Patient.

Portrait of a process: arts-based research in a head and neck cancer clinic.

Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.

A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.

Implementation challenges and opportunities for HIV Treatment as Prevention (TasP) among young men in Vancouver, Canada: a qualitative study.

Creating clinical trial designs that incorporate clinical outcome assessments.

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD).

Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results.

Biology and management of ependymomas.

Isolation and Propagation of Glioma Stem Cells from Acutely Resected Tumors.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

" … it's almost therapeutic, right? Because it's almost like that session that I never had": gay men's accounts of being a participant in HIV research.

An assessment of population-based screening guidelines versus clinical prediction rules for chlamydia and gonorrhea case finding.

Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Sleep-wake disturbance in patients with brain tumors.

Reply to F. Felix et al and M.F. Fay et al.

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.

Trends in Syphilis Partner Notification Among Gay, Bisexual, and Other Men who Have Sex With Men in British Columbia, 2010 to 2013.

Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).

Integrating gender and sex to unpack trends in sexually transmitted infection surveillance data in British Columbia, Canada: an ethno-epidemiological study.

The functional interplay between systemic cancer and the hematopoietic stem cell niche.

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Get Checked… Where? The Development of a Comprehensive, Integrated Internet-Based Testing Program for Sexually Transmitted and Blood-Borne Infections in British Columbia, Canada.

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Clinical presentation and outcomes for adult ependymoma patients.

Need for robust and inclusive public health ethics review of the monitoring of HIV phylogenetic clusters for HIV prevention.

NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

Toward Personalized Targeted Therapeutics: An Overview.